FindTrial
Sign In

Correlation between circulating tumor cell count and absolute lymphocyte count and prognosis in gastric cancer patients

Correlation between circulating tumor cell count and absolute lymphocyte count and prognosis in gastric cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096381
Enrollment
Unknown
Registered
2025-01-22
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Gastric cancer group:None

Sponsors

Affiliated hospital of Guangdong Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Gastric cancer confirmed by pathological biopsy histology; (2) clinically isolated tumor (at the time of initial treatment); (3) At least one peripheral blood CTCs have been collected at the time of initial treatment or postoperative treatment; (4) Age 18 to 80 years old; (5) normal organ function; (6) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) synchronous or metachronous malignancy (at the time of initial treatment); (2) Pregnant and lactating women; (3) Combined with serious lung, heart and other organ diseases; (4) Active bacterial or fungal infection.

Design outcomes

Primary

MeasureTime frame
Disease-free-survival;Overall Survival;—

Countries

China

Contacts

Public ContactLiang Qilian

Affiliated Hospital of Guangdong Medicine University

13822522910@163.com+86 138 2252 2910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026